High cumulative doxorubicin dose for advanced soft tissue sarcoma

BACKGROUND: The recommended cumulative doxorubicin dose in soft tissue sarcoma (STS) treatment was based on cardiotoxicity data from retrospective studies of breast cancer patients. However, the treatment and prognosis of STS and breast cancer are quite different, and reference to breast cancer data...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Tian, Zhichao, Yang, Yang, Yang, Yonghao, Zhang, Fan, Li, Po, Wang, Jiaqiang, Yang, Jinpo, Zhang, Peng, Yao, Weitao, Wang, Xin
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7684756/
https://ncbi.nlm.nih.gov/pubmed/33228579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07663-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados